Gene-edited livestock

Also known as Gene-edited animals, Genome-edited livestock, Gene-edited pigs and cattle

Farm animals with targeted gene edits have reached regulatory decisions. FDA approved a PRRS-resistant pig in 2025 and made a low-risk determination for heat-tolerant cattle in 2022, but broad sales depend on export-market approvals and public acceptance.

Pilot and early commercialDemonstratedReviewed 21 Oct 2026
AI illustration · Illustrative scene, not a photograph of the specific device or experiment.

In plain language

Gene editing tools such as CRISPR can change a specific letter, or a short stretch, of an animal's DNA. Breeders can use this to give an animal a trait that already occurs naturally in some animals, such as a short coat that helps cattle stay cool, or a hornless head so that calves do not need to be dehorned. Because the edit is passed on to offspring, a single edited animal can start a new breeding line.

Two examples have reached formal decisions in the United States. In 2022, the US Food and Drug Administration (FDA) said beef from two gene-edited heat-tolerant cattle, and their offspring, posed a low risk, so the developer could market them without a full FDA approval. In 2025, FDA approved a deletion in a gene called CD163 that makes pigs resistant to porcine reproductive and respiratory syndrome virus (PRRSV), a disease that causes large losses for pig farmers. Only pigs with two copies of the edit were resistant, and they resisted all the virus strains tested except one. Gene editing can also leave unplanned changes in the DNA, so developers must check for them and remove them before animals are sold.

Technical explanation

Gene-edited livestock are produced by introducing a targeted change, called an intentional genomic alteration (IGA), into embryos or cells. In the 2025 PRRS-resistant pig, the sponsor (Genus plc) used CRISPR-Cas9 cuts either side of exon 7 of the swine CD163 gene, so that repair removed the exon. The protein encoded by exon 7 is the part the virus uses to bind to the cell, so pigs with two copies of the deletion (homozygous) resisted all the PRRSV strains tested except KS06, while pigs with one copy (heterozygous) resisted none of the strains tested. FDA's review judged the risk that KS06 would matter as low because that strain does not circulate at an appreciable level in the US.

Off-target and unplanned edits are the main technical risk. For the PRRS pig, FDA's summary reports that the sponsor checked 182 predicted off-target sites, and found unintended edits at two of them in at least one founder pig. FDA says these edits are not expected to affect protein function, and selective breeding removed them from the population intended for commercial use. For polled (hornless) cattle, a 2019 bioRxiv preprint by Norris and colleagues, which analysed publicly available whole-genome sequencing data, reported an unintended heterozygous plasmid integration, along with a second copy of the repair template, at the target site. A UC Davis follow-up on six calves of a gene-edited bull reported that four also inherited a bacterial plasmid fragment, and the authors argue that plasmid integration must be screened for during editing.

Regulation differs by country. In the UK, the Genetic Technology (Precision Breeding) Act 2023 covers both plants and animals, and it defines a precision bred animal. The sources reviewed here did not confirm that the animal-specific rules are in force.

What the evidence says

Each statement is typed by the strength of its evidence and linked to the source that supports it.

Demonstrated Shown in a published experiment, test or shipping product.

On 29 April 2025 FDA approved a deletion of exon 7 of the CD163 gene in domestic pigs, sponsored by Genus plc, for resistance to PRRSV. This was a full approval of the intentional genomic alteration, not a low-risk determination.

Sources: [1] · Date of Approval; Sponsored by; Safety and Effectiveness

Pigs with two copies of the edit (homozygous) resisted all but one PRRSV strain tested, referred to as KS06. Pigs with one copy or none were not resistant to any strain tested.

Sources: [1] · Safety and Effectiveness

FDA judged the risk that the edit would fail against KS06 to be low, because that strain does not circulate at an appreciable level in the US. The sponsor must promptly report post-approval safety or effectiveness problems, such as breakthrough infections in homozygous pigs.

Sources: [1] · Safety and Effectiveness · medium confidence

In the PRRS-resistant pig, the sponsor found unintended edits at two of the 182 predicted off-target sites in at least one founder pig. FDA says these edits are not expected to affect protein function, and selective breeding removed them from the population intended for commercial use.

Sources: [1] · Off-target screening, founder (E0) pigs · medium confidence

In March 2022 FDA made a low-risk determination, under enforcement discretion, for beef from two gene-edited heat-tolerant cattle (PRLR-SLICK) and their offspring. It was the first such determination for an animal intentional genomic alteration used for food.

Sources: [2]

FDA said the PRLR-SLICK alteration does not raise any safety concerns. The edit was made with CRISPR in the PRLR gene and gives a short, slick coat that helps cattle tolerate hot weather.

Sources: [2] · medium confidence

In a UC Davis report on a study of six offspring of a gene-edited hornless bull, four calves also inherited a bacterial plasmid fragment, and two inherited only the natural hornless allele. The study's authors say plasmid integration must be screened for during editing. Van Eenennaam is quoted as saying the plasmid does not harm the animals.

Sources: [4] · medium confidence

The Genetic Technology (Precision Breeding) Act 2023 defines a precision bred organism as a precision bred plant or a precision bred animal, so its scope includes animals. The Act received Royal Assent on 23 March 2023.

Sources: [5] · Section 1; enacted text date

In a 2022 online survey of 848 UK respondents, attitudes to gene-edited meat formed as one package with attitudes to genetic modification in general. The authors expect societal opposition, and say price discounts would not be an effective way to change views. Willingness to pay was highest for the disease-resistance (animal welfare) benefit and lowest for the omega-3 (human health) benefit. The study used chicken breast and a hypothetical bidding game.

Sources: [6] · medium confidence

Reported, unverified Stated by a company or team but not independently confirmed.

A 2019 bioRxiv preprint by Norris and colleagues reported an unintended heterozygous plasmid integration, plus a second copy of the repair template, at the target site in polled (hornless) cattle.

Sources: [3] · Abstract · medium confidence

In April 2025 Genus's Chief Scientific Officer, Elena Rice, said the company would not broadly commercialise the PRRS-resistant pig in the US until it is approved in Mexico. Canadian and Japanese approvals were also still pending at that time.

Sources: [7] · medium confidence

Limitations and open problems

  • The 2025 PRRS-resistant pig protects only pigs with two copies of the edit. Pigs with one copy were not resistant to any strain tested (FDA, 2025).
  • The PRRS-resistant pig was not resistant to the KS06 strain. FDA judged that strain not to circulate at an appreciable level in the US, but this could change, and the sponsor must promptly report post-approval problems, such as breakthrough infections in homozygous pigs.
  • The 2022 cattle decision was a low-risk determination under enforcement discretion, not a full FDA approval. The FDA primary page was not reviewed, so details of that decision rest on a news report.
  • The 2019 preprint argues that screening must reliably detect plasmid and extra repair-template insertions, not only the intended edit.
  • A 2022 UK survey of 848 respondents found that attitudes to gene-edited meat were bundled with attitudes to GM in general. The sample slightly over-represented rural, female and older respondents, and the study used chicken breast and a hypothetical bidding game, so its results may not generalise.
  • The sources reviewed did not confirm the current status of animal-specific UK rules under the Precision Breeding Act 2023, and this profile does not state that status.

Possible future uses

Speculative

Ideas, not predictions. None of these has been demonstrated.

  • Disease-resistant pig herds in countries that accept the edit, which could reduce the need for drugs and vaccines against PRRSV.
  • Heat-tolerant cattle for hot regions, where heat stress lowers weight gain and milk output.
  • Hornless dairy herds that avoid dehorning, provided the edit is made without plasmid insertions.

Timeline

  1. 28 Jul 2019bioRxiv preprint by Norris and colleagues reports unintended plasmid integration at the target site in polled cattle. Sources: [3]
  2. 7 Oct 2019UC Davis reports that four of six calves from a gene-edited hornless bull also inherited a bacterial plasmid fragment. Sources: [4]
  3. Mar 2022FDA issues a low-risk determination, under enforcement discretion, for beef from heat-tolerant PRLR-SLICK cattle. Sources: [2]
  4. 23 Mar 2023The Genetic Technology (Precision Breeding) Act 2023 receives Royal Assent in the UK, covering plants and animals. Sources: [5]
  5. 29 Apr 2025FDA approves the CD163 exon 7 deletion in pigs for PRRS resistance (sponsor Genus plc). Sources: [1]

Futures this could help bring about

Glossary

Intentional genomic alteration (IGA)
A change to an animal's DNA made on purpose with genome editing, which FDA reviews as the regulated product.
Off-target edit
An unplanned change to DNA at a site other than the intended target.
Homozygous and heterozygous
An animal is homozygous for an edit when it has two copies of it, and heterozygous when it has one copy and one unedited copy.
Plasmid
A small loop of DNA, often from bacteria, used as a carrier in genetic engineering; unplanned plasmid DNA in an animal's genome is a sign of an editing error.

Sources

  1. government report
    Freedom of Information Summary, NADA 141-609: Deletion of exon 7 of the CD163 gene in domestic pigs
    US Food and Drug Administration, Center for Veterinary Medicine, 29 Apr 2025. Accessed 21 Oct 2026.
  2. news
    Beef from certain gene-edited cattle is safe to eat, FDA says
    Food Safety News, 9 Mar 2022. Accessed 21 Oct 2026.
  3. preprint
    Template plasmid integration in germline genome-edited cattle
    Alexis L. Norris, Stella S. Lee, Kevin J. Greenlees et al.. bioRxiv, 28 Jul 2019. DOI: 10.1101/715482. Accessed 21 Oct 2026.
  4. university press release
    Genome-Edited Bull Passes on Hornless Trait to Calves
    Amy Quinton. UC Davis News, 7 Oct 2019. Accessed 21 Oct 2026.
  5. government report
    Genetic Technology (Precision Breeding) Act 2023
    legislation.gov.uk, 23 Mar 2023. Accessed 21 Oct 2026.
  6. peer reviewed paper
    Gene-Edited Meat: Disentangling Consumers' Attitudes and Potential Purchase Behavior
    Frontiers in Nutrition, 5 Apr 2022. DOI: 10.3389/fnut.2022.856491. Accessed 21 Oct 2026.
  7. news
    Genus PIC awaits FDA OK as global approval push for PRRS-resistant pigs intensifies
    AgNavigator, 18 Apr 2025. Accessed 21 Oct 2026.

Revision history

3 changes since this profile was created.

Changes on 21 Oct 2026
Published on owner instruction (content loop iteration 49)fddb851
Sources and claims re-checked against originalsfbb434c
Initial profile drafted from primary sources7e66249